Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer | |
Zhang, Jian; Wang, Leiping; Wang, Zhonghua; Wang, Biyun; Cao, Jun; Lv, Fangfang; Zhang, Sheng; Shao, Zhimin; Hu, Xichun | |
刊名 | ONCOTARGET
![]() |
2017 | |
卷号 | 8期号:45 |
关键词 | metronomic chemotherapy oral cyclophosphamide docetaxel metastatic breast cancer |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3616156 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Zhang, Jian,Wang, Leiping,Wang, Zhonghua,et al. Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer[J]. ONCOTARGET,2017,8(45). |
APA | Zhang, Jian.,Wang, Leiping.,Wang, Zhonghua.,Wang, Biyun.,Cao, Jun.,...&Hu, Xichun.(2017).Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer.ONCOTARGET,8(45). |
MLA | Zhang, Jian,et al."Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer".ONCOTARGET 8.45(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论